Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...

Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...

Liver cancer is the fourth most common cancer and the fourth leading cause of cancer-related deaths in the country.

The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...